$DSGN Design Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Design Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Design Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Design Therapeutics, Inc. for free.
IRS Number: 823929248
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: DSGN
Company Address: 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD 92011
Phone number: 858-293-4900
Design Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2021 | DSGN | Design Therapeutic ... | Jeffries Sean | Chief Operating Off ... | Buy | P | 20.00 | 3,050 | 61,000 | 3,050 | 0 to 3.1 K |
| Apr 01 2021 | DSGN | Design Therapeutic ... | Quan Venture Fund II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 458,016 | 0 | 0 | |
| Apr 01 2021 | DSGN | Design Therapeutic ... | Quan Venture Fund II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,236,938 | 0 | 0 | |
| Apr 01 2021 | DSGN | Design Therapeutic ... | Quan Venture Fund II, L.P. | 10% Owner | Buy | C | 0.00 | 280,991 | 0 | 4,720,830 | 4.4 M to 4.7 M (+6.33 %) |
| Apr 01 2021 | DSGN | Design Therapeutic ... | Quan Venture Fund II, L.P. | 10% Owner | Buy | C | 0.00 | 4,439,839 | 0 | 4,439,839 | 0 to 4.4 M |
| Apr 01 2021 | DSGN | Design Therapeutic ... | SR One Capital Fund I Aggregat ... | 10% Owner | Option Exercise | C | 0.00 | 1,526,718 | 0 | 0 | |
| Apr 01 2021 | DSGN | Design Therapeutic ... | SR One Capital Fund I Aggregat ... | 10% Owner | Option Exercise | C | 0.00 | 7,236,938 | 0 | 0 | |
| Apr 01 2021 | DSGN | Design Therapeutic ... | SR One Capital Fund I Aggregat ... | 10% Owner | Buy | P | 20.00 | 250,000 | 5,000,000 | 5,626,476 | 5.4 M to 5.6 M (+4.65 %) |
| Apr 01 2021 | DSGN | Design Therapeutic ... | SR One Capital Fund I Aggregat ... | 10% Owner | Buy | C | 0.00 | 936,637 | 0 | 5,376,476 | 4.4 M to 5.4 M (+21.10 %) |
| Apr 01 2021 | DSGN | Design Therapeutic ... | SR One Capital Fund I Aggregat ... | 10% Owner | Buy | C | 0.00 | 4,439,839 | 0 | 4,439,839 | 0 to 4.4 M |
| Apr 01 2021 | DSGN | Design Therapeutic ... | Xu Stella | Director | Option Exercise | C | 0.00 | 458,016 | 0 | 0 | |
| Apr 01 2021 | DSGN | Design Therapeutic ... | Xu Stella | Director | Option Exercise | C | 0.00 | 7,236,938 | 0 | 0 | |
| Apr 01 2021 | DSGN | Design Therapeutic ... | Xu Stella | Director | Buy | P | 20.00 | 10,000 | 200,000 | 4,730,830 | 4.7 M to 4.7 M (+0.21 %) |
| Apr 01 2021 | DSGN | Design Therapeutic ... | Xu Stella | Director | Buy | C | 0.00 | 280,991 | 0 | 4,720,830 | 4.4 M to 4.7 M (+6.33 %) |
| Apr 01 2021 | DSGN | Design Therapeutic ... | Xu Stella | Director | Buy | C | 0.00 | 4,439,839 | 0 | 4,439,839 | 0 to 4.4 M |